{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T06:28:16Z","timestamp":1790749696496,"version":"4.1.0"},"reference-count":103,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2003,8,15]],"date-time":"2003-08-15T00:00:00Z","timestamp":1060905600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Reviews in Medical Virology"],"published-print":{"date-parts":[[2003,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Routine and mass administration of oral polio vaccine (OPV) since 1961 has prevented many millions of cases of paralytic poliomyelitis. The public health value of this inexpensive and easily administered product has been extraordinary. Progress of the Global Polio Eradication Initiative has further defined the value of OPV as well as its risk through vaccine\u2010associated paralytic poliomyelitis (VAPP) and vaccine\u2010derived polioviruses (VDPV). Although both are rare, once wild poliovirus transmission has been interrupted by OPV, the only poliomyelitis due to poliovirus will be caused by OPV. Poliovirus will be eradicated only when OPV use is discontinued. This paradox provides a major incentive for eventually stopping polio immunization or replacing OPV, but it also introduces complexity into the process of identifying safe and scientifically sound strategies for doing so. The core post eradication immunization issues include the risk\/benefits of continued OPV use, the extent of OPV replacement with IPV, possible strategies for discontinuing OPV, and the potential for development and licensure of a safe and effective replacement for OPV. Formulation of an informed post eradication immunization policy requires careful evaluation of polio epidemiology, surveillance capability, vaccine availability, laboratory containment, and the risks posed by the very tool responsible for successful interruption of wild poliovirus transmission. Copyright \u00a9 2003 John Wiley &amp; Sons, Ltd.<\/jats:p>","DOI":"10.1002\/rmv.401","type":"journal-article","created":{"date-parts":[[2003,8,21]],"date-time":"2003-08-21T15:59:16Z","timestamp":1061481556000},"page":"277-291","source":"Crossref","is-referenced-by-count":118,"title":["Polio eradication: the OPV paradox"],"prefix":"10.1002","volume":"13","author":[{"given":"Walter R.","family":"Dowdle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"De Gourville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olen M.","family":"Kew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Pallansch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Wood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2003,8,15]]},"reference":[{"key":"e_1_2_1_2_2","volume-title":"Polio: The Beginning of the End","year":"1997"},{"key":"e_1_2_1_3_2","unstructured":"World Health Organization.Report of the Interim Meeting of the Technical Consultation Group on the Global Eradication of Poliomyelitis WHO\/EPI\/GEN\/02. World Health Organization: Geneva 2002."},{"key":"e_1_2_1_4_2","first-page":"720","volume":"43","author":"Centers for Disease Control and Prevention. Certification of Poliomyelitis Eradication\u2014the Americas","year":"1994","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"e_1_2_1_5_2","first-page":"1","volume":"50","author":"Centers for Disease Control and Prevention. Certification of Poliomyelitis Eradication\u2013Western Pacific Region","year":"2000","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"e_1_2_1_6_2","first-page":"572","volume":"51","author":"Centers for Disease Control and Prevention. Certification of Poliomyelitis Eradication\u2013European Region","year":"2002","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"e_1_2_1_7_2","first-page":"95","volume":"76","author":"World Health Organization. Transmission of Wild Poliovirus Type 2\u2014Apparent Global Interruption","year":"2001","journal-title":"Weekly Epidemiol Rec"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.109.2822.85"},{"key":"e_1_2_1_9_2","first-page":"354","volume-title":"Vaccines","author":"Plotkin SA","year":"1999"},{"key":"e_1_2_1_10_2","first-page":"364","volume-title":"Vaccines","author":"Sutter R","year":"1999"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/0092-1157(73)90048-6"},{"key":"e_1_2_1_12_2","first-page":"78","article-title":"Parameters for differentiating vaccine\u2010derived and wild poliovirus strains","volume":"24","author":"Nakano JH","year":"1978","journal-title":"Prog Med Virol"},{"key":"e_1_2_1_13_2","first-page":"196","article-title":"Live, orally given poliovirus vaccine. Effects of rapid mass immunization on population under conditions of massive enteric infection with other viruses\u20141960","volume":"77","author":"Sabin AB","year":"1999","journal-title":"Bull World Health Organ"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1128\/9781555817916.ch38"},{"key":"e_1_2_1_15_2","first-page":"681","article-title":"Eradication of poliomyelitis in Cuba: a historical perspective","volume":"77","author":"Mas LP","year":"1999","journal-title":"Bull World Health Organ"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/5.3.583"},{"key":"e_1_2_1_17_2","first-page":"21","volume":"19","author":"Pan American Health Organization. Director announces campaign to eradicate poliomyelitis from the Americas by 1990","year":"1985","journal-title":"Bull PAHO"},{"key":"e_1_2_1_18_2","volume-title":"Global Eradication of Poliomyelitis by the Year 2000: Resolution of the 41st World Health Assembly","author":"World Health Assembly","year":"1988"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/175.Supplement_1.S105"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a009924"},{"key":"e_1_2_1_21_2","first-page":"98","volume":"77","author":"World Health Organization. Progress towards the global eradication of poliomyelitis","year":"2002","journal-title":"Weekly Epidemiol Rec"},{"key":"e_1_2_1_22_2","first-page":"591","article-title":"Screening of cases of acute flaccid paralysis for poliomyelitis eradication: ways to improve specificity","volume":"70","author":"Andrus JK","year":"1992","journal-title":"Bull World Health Organ"},{"key":"e_1_2_1_23_2","first-page":"723","volume-title":"Field's Virology","author":"Pallansch M","year":"2001"},{"key":"e_1_2_1_24_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.epirev.a018041"},{"key":"e_1_2_1_25_2","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-83-5-1107"},{"key":"e_1_2_1_26_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.37.6.1670-1675.1999"},{"key":"e_1_2_1_27_2","doi-asserted-by":"crossref","first-page":"3252","DOI":"10.1128\/jcm.33.12.3252-3256.1995","article-title":"Molecular characterization of a wild poliovirus type 3 epidemic in The Netherlands (1992 and 1993)","volume":"33","author":"Mulders MN","year":"1995","journal-title":"J Clin Microbiol"},{"key":"e_1_2_1_28_2","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1128\/aem.54.2.371-374.1988","article-title":"Viruses in sewage waters during and after a poliomyelitis outbreak and subsequent nationwide oral poliovirus vaccination campaign in Finland","volume":"54","author":"Poyry T","year":"1988","journal-title":"Appl Environ Microbiol"},{"key":"e_1_2_1_29_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/168.6.1510"},{"key":"e_1_2_1_30_2","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268800052195"},{"key":"e_1_2_1_31_2","unstructured":"World Health Organization.Manual for the Virologic Investigation of Poliomyelitis. WHO\/EPI\/GEN\/02.1. World Health Organization: Geneva 2002."},{"key":"e_1_2_1_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/0166-0934(93)90022-J"},{"key":"e_1_2_1_33_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.32.5.1366-1368.1994"},{"key":"e_1_2_1_34_2","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1128\/jcm.34.12.2990-2996.1996","article-title":"Group\u2010specific identification of polioviruses by PCR using primers containing mixed\u2010base or deoxyinosine residue at positions of codon degeneracy","volume":"34","author":"Kilpatrick DR","year":"1996","journal-title":"J Clin Microbiol"},{"key":"e_1_2_1_35_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.36.2.352-357.1998"},{"key":"e_1_2_1_36_2","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1128\/jcm.33.10.2562-2566.1995","article-title":"Comparative study of five methods for intratypic differentiation of polioviruses","volume":"33","author":"van der Avoort HG","year":"1995","journal-title":"J Clin Microbiol"},{"key":"e_1_2_1_37_2","doi-asserted-by":"crossref","first-page":"2834","DOI":"10.1128\/jcm.35.11.2834-2840.1997","article-title":"Genotype\u2010specific RNA probes for direct identification of wild polioviruses by blot hybridization","volume":"35","author":"De L","year":"1997","journal-title":"J Clin Microbiol"},{"key":"e_1_2_1_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/0168-1702(91)90107-7"},{"key":"e_1_2_1_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/0042-6822(91)90434-D"},{"key":"e_1_2_1_40_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1068284"},{"key":"e_1_2_1_41_2","doi-asserted-by":"publisher","DOI":"10.1128\/9781555817916.ch39"},{"key":"e_1_2_1_42_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.micro.51.1.151"},{"key":"e_1_2_1_43_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.ge.27.120193.002033"},{"key":"e_1_2_1_44_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.64.8.3960-3962.1990"},{"key":"e_1_2_1_45_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.36.10.2893-2899.1998"},{"key":"e_1_2_1_46_2","doi-asserted-by":"publisher","DOI":"10.1006\/viro.1999.0003"},{"key":"e_1_2_1_47_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.74.7.3001-3010.2000"},{"key":"e_1_2_1_48_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.74.16.7381-7390.2000"},{"key":"e_1_2_1_49_2","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-71-2-317"},{"key":"e_1_2_1_50_2","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.1890350415"},{"key":"e_1_2_1_51_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.74.23.11153-11161.2000"},{"key":"e_1_2_1_52_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0042-6822(88)90113-4"},{"key":"e_1_2_1_53_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.68.12.8089-8101.1994"},{"key":"e_1_2_1_54_2","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-76-9-2343"},{"key":"e_1_2_1_55_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.76.21.10921-10928.2002"},{"key":"e_1_2_1_56_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.38.3.945-952.2000"},{"key":"e_1_2_1_57_2","unstructured":"World Health Organization.Report of the Second Meeting of the Technical Consultation Group for Global Eradication of Poliomyelitis WHO\/EPI\/GEN\/98.04. World Health Organization: Geneva 1998."},{"key":"e_1_2_1_58_2","unstructured":"TerryLL.The Association of Cases of Poliomyelitis with the Use of Type III Oral Poliomyelitis Vaccines. U.S. Department of Health Education and Welfare1962."},{"key":"e_1_2_1_59_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.305.6845.79"},{"key":"e_1_2_1_60_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/14.2.568"},{"key":"e_1_2_1_61_2","first-page":"33","article-title":"Risk of vaccine\u2010associated paralytic poliomyelitis in Latin America, 1989\u201391","volume":"73","author":"Andrus JK","year":"1995","journal-title":"Bull World Health Organ"},{"key":"e_1_2_1_62_2","first-page":"210","article-title":"Vaccine\u2010associated paralytic poliomyelitis in India during 1999: decreased risk despite massive use of oral polio vaccine","volume":"80","author":"Kohler KA","year":"2002","journal-title":"Bull World Health Organ"},{"key":"e_1_2_1_63_2","first-page":"987","article-title":"Further clarity on vaccine\u2010associated paralytic polio in India","volume":"80","author":"Kohler KA","year":"2002","journal-title":"Bull World Health Organ"},{"key":"e_1_2_1_64_2","first-page":"917","article-title":"Vaccine\u2010associated paralytic polio in India","volume":"80","author":"John TJ","year":"2002","journal-title":"Bull World Health Organ"},{"key":"e_1_2_1_65_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.69.8.4972-4978.1995"},{"key":"e_1_2_1_66_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.65.3.1377-1382.1991"},{"key":"e_1_2_1_67_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.63.11.4949-4951.1989"},{"key":"e_1_2_1_68_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.63.3.1338-1344.1989"},{"key":"e_1_2_1_69_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/175.Supplement_1.S176"},{"key":"e_1_2_1_70_2","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(90)90168-E"},{"key":"e_1_2_1_71_2","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-69-5-1091"},{"key":"e_1_2_1_72_2","doi-asserted-by":"publisher","DOI":"10.1006\/viro.1993.1003"},{"key":"e_1_2_1_73_2","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-73-12-3065"},{"key":"e_1_2_1_74_2","first-page":"133","article-title":"Expanding contributions of the Global Laboratory Network for Poliomyelitis Eradication, 2000\u20132001","volume":"77","author":"World Health Organization","year":"2002","journal-title":"Weekly Epidemiol Rec"},{"key":"e_1_2_1_75_2","first-page":"72","article-title":"Hypogammaglobulinaemia in the United Kingdom. VII. The role of humoral antibodies in protection against and recovery from bacterial and virus infections in hypogammaglobulinaemia","volume":"310","author":"MacCallum FO","year":"1971","journal-title":"Spec Rep Ser Med Res Counc (G.B)"},{"key":"e_1_2_1_76_2","first-page":"426","article-title":"Vaccine\u2010associated paralytic poliomyelitis among immunodeficient persons","volume":"11","author":"Sutter R","year":"1994","journal-title":"Infect Med"},{"key":"e_1_2_1_77_2","first-page":"347","article-title":"Stopping poliovirus vaccination after eradication: issues and challenges","volume":"78","author":"Wood D","year":"2000","journal-title":"Bull World Health Organ"},{"key":"e_1_2_1_78_2","doi-asserted-by":"publisher","DOI":"10.1086\/338262"},{"key":"e_1_2_1_79_2","first-page":"874","article-title":"Acute flaccid paralysis associated with circulating vaccine\u2010 derived poliovirus\u2014Philippines","volume":"50","author":"Centers for Disease Control and Prevention","year":"2001","journal-title":"Morb Mortal Wkly Rep"},{"key":"e_1_2_1_80_2","first-page":"174","volume-title":"Poliomyelitis due to vaccine\u2010derived polio viruses in the Philippines","author":"Thorley B","year":"2002"},{"key":"e_1_2_1_81_2","first-page":"622","volume":"51","author":"Centers for Disease Control and Prevention","year":"2002","journal-title":"Morb Mortal Wkly Rep"},{"key":"e_1_2_1_82_2","first-page":"41","article-title":"Circulation of a type 2 vaccine\u2010derived poliovirus\u2014Egypt, 1982\u20131993","volume":"50","author":"Centers for Disease Control and Prevention","year":"2001","journal-title":"Morb Mortal Wkly Rep"},{"key":"e_1_2_1_83_2","first-page":"305","article-title":"Progress toward poliomyelitis eradication\u2014Egypt","volume":"51","author":"Centers for Disease Control and Prevention","year":"2002","journal-title":"Morb Mortal Wkly Rep"},{"key":"e_1_2_1_84_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.77.15.8366-8377.2003"},{"key":"e_1_2_1_85_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a112848"},{"key":"e_1_2_1_86_2","first-page":"622","article-title":"Public health dispatch: poliomyelitis\u2014Madagascar","volume":"51","author":"Centers for Disease Control and Prevention","year":"2002","journal-title":"Morb Mortal Wkly Rep"},{"key":"e_1_2_1_87_2","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1128\/jvi.63.3.1302-1309.1989","article-title":"Determinants in the 5\u2032 noncoding region of poliovirus Sabin 1 RNA that influence the attenuation phenotype","volume":"63","author":"Kawamura N","year":"1989","journal-title":"J Virol"},{"key":"e_1_2_1_88_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1044-5773(05)80017-4"},{"key":"e_1_2_1_89_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.76.13.6791-6799.2002"},{"key":"e_1_2_1_90_2","volume-title":"Smallpox and Its Eradication","author":"World Health Organization","year":"1988"},{"key":"e_1_2_1_91_2","unstructured":"World Health Organization.Report of the First Meeting of the Technical Consultation Group for Global Eradication of Poliomyelitis WHO\/EPI\/GEN\/96.04. World Health Organization: Geneva 1996."},{"key":"e_1_2_1_92_2","volume-title":"Global Eradication of Poliomyelitis: Report of the Meeting on the Scientific Basis for Stopping Polio Immunization","author":"World Health Organization","year":"2003"},{"key":"e_1_2_1_93_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.277.5327.779"},{"key":"e_1_2_1_94_2","doi-asserted-by":"publisher","DOI":"10.1086\/323897"},{"key":"e_1_2_1_95_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1071207"},{"key":"e_1_2_1_96_2","first-page":"57","volume-title":"Considerations for Viral Disease Eradication: Lessons Learned and Fututre Strategies","author":"Dowdle WR","year":"2002"},{"key":"e_1_2_1_97_2","first-page":"1","article-title":"Poliomyelitis prevention in the United States: updated recommendations of the ACIP","volume":"49","author":"Centers for Disease Control and Prevention","year":"2000","journal-title":"Morb Mortal Wkly Rep"},{"key":"e_1_2_1_98_2","unstructured":"World Health Organization.WHO Global Action Plan for Laboratory Containment of Wild Polioviruses. WHO\/V&B\/99.32. World Health Organization: Geneva 1999."},{"key":"e_1_2_1_99_2","unstructured":"World Health Organization.Guidelines for the Safe Production and Quality Control of IPV Manufactured from Wild Polioviruses.WHO Technical Report Series. WHO: Geneva 2003(in press)."},{"key":"e_1_2_1_100_2","first-page":"311","article-title":"Can post\u2010eradication laboratory containment of wild polioviruses be achieved?","volume":"80","author":"Dowdle WR","year":"2002","journal-title":"Bull World Health Organ"},{"key":"e_1_2_1_101_2","first-page":"993","article-title":"Global progress toward laboratory containment of wild polioviruses\u2014July 2001\u2013August 2002","volume":"51","author":"Centers for Disease Control and Prevention","year":"2002","journal-title":"Morb Mortal Wkly Rep"},{"key":"e_1_2_1_102_2","unstructured":"AndrusJK AshleyD DowdleWR Global Health Forum III.Post\u2010Certification Polio Immunization Policy. Report No.:III. Institute for Global Health: San Francisco 2002."},{"key":"e_1_2_1_103_2","volume-title":"Molecular Biology of Picornaviruses","year":"2002"},{"key":"e_1_2_1_104_2","volume-title":"Global Eradication of Poliomyelitis: Report of the Third Meeting of the Global Commission for the Certification of the Eradication of Polio","author":"World Health Organization","year":"1998"}],"container-title":["Reviews in Medical Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Frmv.401","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/rmv.401","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T20:25:21Z","timestamp":1700252721000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/rmv.401"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,8,15]]},"references-count":103,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2003,9]]}},"alternative-id":["10.1002\/rmv.401"],"URL":"https:\/\/doi.org\/10.1002\/rmv.401","archive":["Portico"],"relation":{},"ISSN":["1052-9276","1099-1654"],"issn-type":[{"value":"1052-9276","type":"print"},{"value":"1099-1654","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,8,15]]}}}